期刊文献+

氯化钴低氧对黑色素瘤细胞系迁移能力及FSTL1表达分泌的影响

Effects of cobalt chloride-induced hypoxia on cell migration and expression and secretion of FSTL1 in melanoma cell line
下载PDF
导出
摘要 目的探讨氯化钴(CoCl_2)化学模拟低氧对黑色素瘤细胞系B16F10迁移的影响,以及Follistatin-like 1(FSTL1)蛋白在此过程中的转录、表达和分泌情况。方法 CoCl_2模拟低氧作用于小鼠B16F10细胞,实验分为3组:0μmol/L CoCl_2对照组、50μmol/L和100μmol/L CoCl_2处理组。用MTT法测定细胞活力;用Transwell法测定细胞迁移能力;qRT-PCR检测Fstl1 m RNA表达;Western blot检测细胞内外FSTL1蛋白表达。结果 CoCl_2模拟低氧可以导致B16F10细胞存活率显著下降,并呈浓度和时间依赖性;50μmol/L CoCl_2处理组(0.158±0.006)、100μmol/L CoCl_2处理组(0.203±0.002)B16F10细胞迁移能力均明显高于对照组(0.107±0.001,均P<0.05);50μmol/L CoCl_2处理组(1.573±0.114)、100μmol/L CoCl_2处理组(2.219±0.085)Fstl1 m RNA表达均显著高于对照组(0.962±0.054,均P<0.05),而胞内FSTL1蛋白表达与Fstl1 m RNA表达趋势一致。同时也发现,CoCl_2处理组细胞外FSTL1蛋白表达均低于对照组,且100μmol/L CoCl_2处理组几乎检测不到FSTL1表达。结论 CoCl_2模拟低氧促进黑色素瘤细胞迁移,可能与FSTL1的表达和分泌有关,但其功能和作用机制还需进一步探讨。 Objective To explore the effects of cobalt chloride(CoCl_2)-induced hypoxia on migration of melanoma cells, and to detect the transcription, expression and secretion of Follistatin-like 1(FSTL1) in this process. Methods B16F10 melanoma cell line was treated with CoCl_2 in order to mimic hypoxia. Experimental cells were divided into three groups: 0μmol/L, 50 μmol/L and 100 μmol/L CoCl_2 treatment groups. MTT assay was used to assure cell viability, and to determine the treatment concentration of CoCl_2. Transwell assay was used to determine the migration ability of B16F10 melanoma cell line. Real-time PCR was used to measure the m RNA expression of Fstl1. Western blot assay was used to detect the intracellular and extracellular protein expression of FSTL1. Results The cell viability of B16F10 melanoma cell line was significantly reduced by CoCl_2 treatment, with a time and concentration-dependent manner. The migration ability of B16F10 cell line was significantly increased in CoCl_2 treated group compared with that of control group(P 0.05). The m RNA level of Fstl1 was obviously higher in CoCl_2 treated group than that of control group(P 0.05). The intracellular expression of FSTL1 protein was consistent with the expression trend of Fstl1 m RNA. Simultaneously, the extracellular protein level of FSTL1 was significantly decreased compared with that of control group. There was no expression of FSTL1 in 100 μmol/L CoCl_2 treatment group. Conclusion The migration ability of melanoma cell line is enhanced by CoCl_2 treatment, which may be associated with expression and secretion of FSTL1, however, the relevant mechanism still needs further investigation.
出处 《天津医药》 CAS 2016年第3期294-297,共4页 Tianjin Medical Journal
基金 国家十二五科技支撑计划(2012BAI05B02)
关键词 黑色素瘤 细胞运动 细胞低氧 氯化钴 迁移 FSTL1 melanoma cell movement cell hypoxia cobalt chloride migration follistatin-like 1
  • 相关文献

参考文献15

  • 1Meijer TW, Kaanders JH, Span PN, et al.Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy [J]. Clin Cancer Res, 2012, 18(20):5585-5594. doi: 10,1158/1078- 0432.CCR- 12-0858.
  • 2Shibanuma M, Mashimo J, Mita A, et al. Cloning from a mouse os- teoblastic cell line of a set of transforming-growth-factor-beta 1- regulated genes, one of which seems to encode a follistatin-relatedpolypeptide [J]. Eur J Biochem, 1993, 217(1):13-19.
  • 3Sumitomo K, Kurisaki A, Yamakawa N, et al.Expression of a TGF- betal inducible gene, TSC-36, causes growth inhibition in human lung cancer cell lines[J]. Cancer Lett, 2000, 155(1):37-46.
  • 4刘薇,张翠翠,王晶,李凯.抗血管生成药物增加血清饥饿环境中MDA—MB-231乳腺癌细胞的侵袭和迁移能力[J].中华肿瘤杂志,2015,37(4):244-250. 被引量:2
  • 5Kundra V, Escobedo JA, Kazlauskas A, et al.Regulation of chemo- taxis by the platelet-derived growth factor receptor-beta[J]. Nature, 1994, 367(6462):474-476.doi: 10,1038/367474a0.
  • 6Ryan HE, Poloni M, McNuhy W, et al.Hypoxia-inducible factor- lalpha is a positive factor in solid tumor growth[J]. Cancer Res, 2000, 60(15):4010-4015.
  • 7Kim KS, Rajagopal V, Gonsalves C, et al.A novel role of hypoxia-in- ducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells[J]. J Immunol, 2006, 177(10):7211-7224.
  • 8Esterberg R, Delalande JM, Fritz A. Tailbud-derived Bmp4 drives proliferation and inhibits maturation of zebrafish chordamesoderm [J]. Development, 2008, 135(23):3891-3901. doi: 10,1242/dev.0292 64.
  • 9Geng Y, Dong Y, Yu M, et al. Follistatin-like 1 (Fstll) is a bone morphogenetic protein (BMP) 4 signaling antagonist in controlling mouse lung development [J]. Proc Natl Acad Sci USA, 2011, 108 (17):7058-7063.doi: 10,1073/pnas. 1007293108.
  • 10Li D, Wang Y, Xu N, et al. Follistatin-like protein 1 is elevated in systemic autoimmune diseases and correlated with disease activity in patients with rheumatoid arthritis [J]. Arthritis Res Ther, 2011, 13 (1):R17. doi: 10,1186/ar3241.

二级参考文献11

  • 1Ebos 1M, Lee CR, Cruz-Munoz W, et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis[J]. Cancer Cell, 2009, 15(3) :232-239.
  • 2Pennacchietti S, Michieli P, Galluzzo M, et al, Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene[J] , Cancer Cell, 2003, 3(4) :347-361.
  • 3Cairns RA, Khokha R, Hill RP. Molecular mechanisms of tumor invasion and metastasis: an integrated view[J]. CUIT Mol Med, 2003, 3( 7) :659-671.
  • 4Mmjon PL, Bobrovnikova-Mmjon EV, Abcouwer SF. Expression of the pro-angiogenic factors vascular endothelial growth factor and interleukin-8ICXCL8 by human breast carcinomas is responsive to nutrient deprivation and endoplasmic reticulum stress[1 I. Mol Cancer, 2004, 3:4.
  • 5Wang F, Li Y, Zhou 1, et al. miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SPI[J]. Am 1 Pathol, 2011, 179 (5) :2580-2588.
  • 6Shi Q, Le X, Abbruzzese IL, et al, Constitutive Sp l activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma[J] . Cancer Res, 2001, 61 (10) :4143-4154.
  • 7Iungert K, Buck A, von Wichert G, et al. Sp 1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells[J]. Cancer Res, 2007, 67( 4) : 1563-1570.
  • 8ima DO, ZhangJ,Jacobs C, et al. Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs[J]. Blood, 2010, 116 (23) :eIl8-eI27.
  • 9Kerbel RS. Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer[J]. Breast, 2009, 18 (SuppI3) :541-547.
  • 10Boehm T, Folkman 1, Browder T, et al, Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance[J] . Nature, 1997,390(6658) :404-407.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部